A UK-based research institute with world recognised expertise in the area of infectious disease research is offering its capabilities to industrial partners as well as universities and research organisations in developing innovations in the diagnosis and treatment of COVID-19. It is envisaged that the partnerships will take the form of research cooperation agreements, technical cooperation agreements or commercial agreements with technical assistance.
The current COVID-19 pandemic is one of the greatest global health crisis ever faced. It will require a transnational and cross-discipline approach to research and innovation to find better diagnostics, new treatments, vaccines and to understand the epidemiology and prognostic factors behind the disease. A UK-based research institute has world renowned expertise in the area of infectious diseases especially in the rapid translation of infectious diseases research with a primary focus to combat the threats of resistance to public health across the globe. With over 500 researchers the institute has a proven track record working with industry through the whole development pathway and is currently contributing to products currently in clinical development including therapeutics, diagnostics, vaccines, including multiple projects related to COVID-19. The research institute is offering its capabilities to partner with companies, research institutions and universities working on innovations in coronavirus and COVID-19 research. This can be diagnostics, therapeutics or preventatives measures such as vaccines. The institute will provide partners with access to its knowledge, facilities and capabilities. The institute will use the knowledge transfer resulting from these partnerships to further develop their capabilities and knowledge base. It is envisaged that the partnerships will take the form of research cooperation agreements, technical cooperation agreements or commercial agreements with technical assistance, depending on the individual circumstances of the partner.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
The UK research institution is looking to partner with companies in particular but also with universities and other research organisations that are developing new diagnostics and treatments for COVID-19. The UK research institute will provide assistance to the partner in terms of consultation in a wide range of areas including genomics, biomarkers both diagnostic and prognostic, pathogen biology, epidemiology, drug discovery, virology and vaccines. The UK research institute will use the information generated through these partnerships to further develop its capabilities and expertise and enhance its offer as well as contribute to the research and innovation against coronavirus. It is expected that the partnerships will take the form of research cooperation agreements, technical cooperation agreements or commercial agreements with technical assistance depending on circumstances.
Stage of Development:
Already on the market